Program:
Start Year:
2023
Why did you choose Duke for your residency training?
I had the privilege of training at Duke for medical school, which allowed me early exposure to the incredible ob/gyn department here. I truly believe that the people at Duke are one of kind, and as a result, our residency program is too! The emphasis on patient-centered care, supportive learning environment for trainees and strong mentorship in the department are just a few examples of why I chose to train here.
What excites you about the residency program at Duke Ob/Gyn?
I want to get the most out of my four years of residency, so exposure to the many available subspecialties here is really exciting to me. Additionally, we serve a diverse patient population here in Durham, and Duke’s commitment to addressing maternal health disparities is something that I am passionate about and excited to be able to contribute to.
What are your career goals?
I have loved the teaching and research opportunities found in academic medicine thus far, so I aspire to practice in an academic setting. Whether I follow my early interest in gynecologic oncology, or find a passion for another field during my clinical rotations, I hope to have a career where I remain clinically curious and find deep meaning in serving my patients.
Describe your research interests/goals:
I'd like to continue building on my foundation in quality improvement and health outcomes research. My goal is ultimately to help change clinical guidelines to improve patient care through my research.
What are your hobbies?
I love staying active at the gym, on my Peloton or by practicing yoga! I also love sleeping in, jaunting around the Durham farmers' market on Saturday mornings and scoping out local concerts.
Education & Training
Undergraduate school & graduation year:
University of Connecticut, 2019
Medical school & graduation year:
Duke University School of Medicine, 2023
Awards & Honors
Gynecologic Oncology Research Scholarship Recipient, 2021
Publications
Wickenheisser, NE; Craig, AM; Kuller, JA; Dotters-Katz, SK. (In press) The risks and benefits of monoclonal antibody therapy during pregnancy and postpartum: Maternal, obstetric, and neonatal considerations. Obstetric and Gynecologic Survey.
Monuszko, KA, Fish, LJ, Sparacio, D, Lizaso, C, Burn, K, Wickenheisser, NE, Meyer, LA, Reed, SD, Davidson, BA, Havirlesky, LJ. (2022, October). “Understanding the needs and perspectives of ovarian cancer patients when considering PARP inhibitor maintenance therapy: Findings from two online community events.” Gynecologic Oncology Reports.
Presentations
Wickenheisser N, Dillon, M; Broadwater, G; Havrilesky, L. et. al. (2022, September 9). “Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: a multi-site analysis.” Poster presented at the 2023 Annual Meeting of the Society of Gynecologic Oncology, Tampa, Florida, United States, March 27, 2023
Wickenheisser N, Dillon, M; Broadwater, G; Havrilesky, L. et.al. (2022, September 9). “Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: a multi-site analysis.” Poster presented at the 2022 Mid-Atlantic Gynecologic Oncology Society Annual Meeting, Nashville, Tennessee, United States, September 9, 2022
Wickenheisser N, Gray B, Gesher C, Baldwin M, Barber M, Dotters-Katz S. "Living in Virtual Reality: The Impact of Virtual Grand Rounds on Trainee and Faulty Attendance.” Oral presentation at the 2022 CREOG & APGO Annual Meeting, Orlando, Florida, March 11, 2022
Wickenheisser N, Kurtovic K, Dodd S, Smith G, Witte M, Havrilesky L. “Assessing differences in postoperative sequential compression device (SCD) adherence in post-operative patients.” Poster presented at the 2022 North Carolina Obstetrics & Gynecology Society Annual Meeting, Kiawah Island, South Carolina, United States, April 9, 2022
Wickenheisser N, Zambrano Guevara L, Moyett J, Bloom E, Kurtovic K, Dodd S, Smith G, Witte M, Altonji S, Lester P, Long O, Havrilesky L. Assessing differences in postoperative sequential compression device (SCD) adherence in post-operative patients.” Poster presented at the 2022 Duke Quality Conference, Durham, North Carolina, United States, March 22, 2022
Goins, C, Wickenheisser, N, Kurtovic, K, Galilea, L, Wagner, E, Moss, H, Strickland, K, Havrilesky, L. “Standardizing the Use and Reporting of the Sectioning and Extensively Examining the Fimbriated End (SEE-FIM) Protocol at Duke University Hospital” Poster presented at the 2022 Duke Quality Conference, Durham, North Carolina, March 22nd, 2022
Wickenheisser N, Davidson B, Moss, H, Dillon, M, Broadwater, G, Havrilesky, L. “Associations between the COVID-19 pandemic, stage distribution at diagnosis, and radical hysterectomy case volume for treatment of cervical cancer: Preliminary data from the Duke Cancer Institute.” Poster presentation at the 2022 Annual Medical Student Research Symposium, Durham, North Carolina, United States, August 5, 2022